HPV18 E6E7 antisense fluorescence eukaryotic expression vector and its expression in cervical cancer HeLa cells.docVIP

  • 5
  • 0
  • 约1.36万字
  • 约 16页
  • 2017-05-03 发布于浙江
  • 举报

HPV18 E6E7 antisense fluorescence eukaryotic expression vector and its expression in cervical cancer HeLa cells.doc

HPV18 E6E7 antisense fluorescence eukaryotic expression vector and its expression in cervical cancer HeLa cells

 PAGE \* MERGEFORMAT 16 HPV18 E6E7 antisense fluorescence eukaryotic expression vector and its expression in cervical cancer HeLa cells Author: Secretary Marnie, Wang Wei, Tian Xun, Luo Ai-month, LI Chun-xiao, Wang Juan, LU Yun-Ping, Shi-Xuan Wang, Martin 【Abstract】 Objective To construct the HPV18-type E6E7 antisense fluorescence eukaryotic expression vector, and to observe their cervical cancer HeLa cells, HPV18 E6 and E7 gene expression, to explore the clinical anti-sense technology for the treatment of the possibility of HPV infection and cervical cancer . Methods The HPV18-based whole-genome plasmid as a template, PCR amplified HPV18-type E6E7 area 716bp fragment, using recombinant technology to insert a fluorescent reverse fragment of eukaryotic expression vector pEGFP  C1, EcoR I digestion and sequencing; Lipid transfer method using the recombinant plasmid pEGFP  HPV18E6E7as (EGFP  18AS) transfected HeLa cervical cancer cell lines by RT  PCR and western blot detection of cell E6, E7 mRNA and protein expression. The results successfully constructed HPV18 E6E7 antisense fluorescence eukaryotic expression vector EGFP  18AS, by lipofection HeLa cells, 48h after the inverted fluorescence microscope, clearly visible under the green fluorescence, and the cell E6, E7 mRNA and protein expression were significantly down-regulated. Conclusion fluorescent antisense eukaryotic expression vector can effectively inhibit HPV18 E6, E7 oncogene expression, for the treatment of HPV infection and cervical cancer provides a new approach. Keywords: human papillomavirus type 18; E6/E7; Antisense; EGFP; cervical cancer Cervical cancer is a common malignancy of women in the global context, its incidence second only to breast cancer, but its incidence in many developing countries ranked first, accounting for 25% of the total number of female malignancies [1] . Studies have shown that 99% of cervical cancer can be detected in human papilloma vi

文档评论(0)

1亿VIP精品文档

相关文档